Thomas Jang

About

Dr. Thomas Jang is the Associate Chief of Urologic Oncology at Rutgers Cancer Institute of New Jersey. His research focuses on urologic oncology, with recent articles addressing perioperative care for radical cystectomy, penile metastasis in colorectal carcinoma, and factors influencing urology residency matches. He is also involved in studies examining the impact of genomic analysis on prostate cancer outcomes and addressing disparities in survival rates among different demographic groups.